Unlike previous studies suggesting clock dysfunctions in tumors or tumor suppressive roles of clock genes, emerging evidence has revealed that circadian clocks function in favor of the development and maintenance of CSCs, particularly in brain and blood cancers. The gene discussed is CLOCK; the disease is neoplasm.